Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2007

Content (15 Articles)

Obituary

Obituary

Marc Lippman

Pre clinical Study

A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer

P. Gajalakshmi, Thanemozhi G. Natarajan, Deepa Selvi Rani, K. Thangaraj

PRECLINICAL STUDY

Differential Effects of Omega-3 and Omega-6 fatty Acids on Gene Expression in Breast Cancer Cells

Rasha Hammamieh, Nabarun Chakraborty, Stacy-Ann Miller, Edward Waddy, Mohsen Barmada, Rina Das, Sheila A. Peel, Agnes A. Day, Marti Jett

PRECLINICAL STUDY

Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients

Christian Schindlbeck, Udo Jeschke, Sandra Schulze, Uwe Karsten, Wolfgang Janni, Brigitte Rack, Stan Krajewski, Harald Sommer, Klaus Friese

Clinical Trial

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

Khalid El Ouagari, Jon Karnon, Thomas Delea, Willena Talbot, Jane Brandman

Clinical trial

Women’s Anxieties Caused by False Positives in Mammography Screening: A Contingent Valuation Survey

Hideo Yasunaga, Hiroo Ide, Tomoaki Imamura, Kazuhiko Ohe

Epidemiology

Breast Cancer Risk is not Associated with Polymorphic Forms of Xeroderma Pigmentosum Genes in a Cohort of Women from Washington County, Maryland

T. J. Jorgensen, K. Visvanathan, I. Ruczinski, L. Thuita, S. Hoffman, K. J. Helzlsouer

Epidemiology

A Study on the Association of Cytochrome-P450 1A1 Polymorphism and Breast Cancer Risk in North Indian Women

Virendra Singh, Neeraj Rastogi, Ashima Sinha, Abhai Kumar, Neeraj Mathur, Mahendra Pratap Singh

Epidemiology

Polymorphisms in the KDR and POSTN Genes: Association with Breast Cancer Susceptibility and Prognosis

Asta Försti, Qianren Jin, Andrea Altieri, Robert Johansson, Kerstin Wagner, Kerstin Enquist, Ewa Grzybowska, Jolanta Pamula, Wioletta Pekala, Göran Hallmans, Per Lenner, Kari Hemminki

Epidemiology

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs

Peter A. Fasching, Gunter von Minckwitz, Thorsten Fischer, Manfred Kaufmann, Beate Schultz-Zehden, Heike Beck, Michael P. Lux, Volker Jacobs, Harald Meden, Marion Kiechle, Matthias W. Beckmann, Stefan Paepke

Epidemiology

Early arm swelling after breast surgery: changes on both sides

Terry P. Haines, Patricia Sinnamon

Epidemiology

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

Matthew P. Goetz, Stacey K. Knox, Vera J. Suman, James M. Rae, Stephanie L. Safgren, Matthew M. Ames, Daniel W. Visscher, Carol Reynolds, Fergus J. Couch, Wilma L. Lingle, Richard M. Weinshilboum, Emily G. Barr Fritcher, Andrea M. Nibbe, Zeruesenay Desta, Anne Nguyen, David A. Flockhart, Edith A. Perez, James N. Ingle

Letter to the Editor

Fulvestrant in Advanced Male Breast Cancer

Amit Agrawal, Kwok-Leung Cheung, John FR Robertson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine